A small Russian company from the Novosibirsk has developed test systems based on protein immunochips for simultaneous diagnosis of up to 12 human infectious diseases such as urogenital infections, TORCH infections, etc. Analyses could be done up to 12 times faster than by traditional ways. The manufacturing cost of the test systems offered is 2-3.5 times lower than manufacturing cost of ELISA test systems. The company is interested in joint-venture and is looking for distributors.
The Russian company specialized in test systems development and production is interested in joint venture and is looking for potential distributors. The company develops diagnostic test system, which is a compact 16 x 10 x 10 cm kit that includes solid protein matrix in a form of a comb and multicellular bath with operating solutions. The surface of the protein matrix is covered discretely by antigens of different human infectious diseases for multi-purpose diagnosis. The antigens are located on the matrix in a certain order. Results of immunoassay are indicated by color signals in certainly defined zones of antigens location. It can be used for detection of the following infections: 1) urogenital infections (chlamydiosis, ureaplasmosis, mycoplasmosis, trichomoniasis, gardnerellosis etc.); 2) TORCH infections (rubella, toxoplasmosis, cytomegalovirus infection, herpes); 3) transmissible infections (HIV, syphilis, hepatitis A, B, C); 4) zoogenous infections (listerellosis, brucellosis, leptospirosis); 5) helminthoses (opisthorchis, lambliasis, toxocariasis). The company has been established in 1993 and has entered the CIS markets and China.
Innovations and advantages
The diagnostic test systems offered are based on protein immunochips for detecting by one analysis of up to 12 antibodies of human infectious diseases at concentration of 5 ng / ml. The sensitivity and specificity of the test systems developed are the same as those of traditional methods for diagnosis. A special method for immunochemical assay provides visual account of results. The use of the test systems does not require stationary equipment and energy supply and they could be used at poorly equipped laboratories and in rural areas, in mobile hospitals.
Market application codes
05001001 Diagnostic services
Intellectual property rights
Area of partner's activity
- Type of partner sought: a company, biomedical laboratory or research organization. - Specific area of activity of the partner: production of diagnostic test systems or equipment; a biomedical laboratory or research organization that carries out research in new diagnostic test systems and conduct trials. - Tasks to be performed: technical and financial assistance in establishing joint manufacture of test systems based on immunochips. If a partner is a biomedical laboratory or research organization it is expected to provide quality control, further joint research, assistance in certification and trials. Commercial agreement for distribution of test and reagent kits.